We are excited to work with dedicated addiction treatment providers and fellow entrepreneurs that are committed to improving treatment outcomes. We are being approached by more MOUD organizations that understand the benefit of an all-in-one solution that fits their unique needs.

ORLANDO, Fla. (PRWEB)
October 07, 2021

AZZLY, Inc., a leading behavioral and addiction treatment digital health solution, announced today that it has partnered with Computalogic®, a specialty Opioid Treatment Program (OTP) solutions provider. The new partnership enables OTP clinics to expand the services they provide and programs offered to serve the vast number of individuals suffering from substance use disorder in every community.

AZZLY Rize™ is a leading digital health solution serving the growing ambulatory outpatient treatment market that offers medication for opioid use disorder (MOUD). AZZLY is recognized for its “purpose built” all-in-one EHR, Patient Management and Revenue Cycle Management software for behavioral healthcare organizations. Some of those features include patient-provider criteria matching, an auditor-friendly chronological eChart, HIPAA compliant telehealth, Mediation Management, My Work alerts, and seamless billing and claims submissions to speed reimbursements.

MethodOne was designed by a team experienced in OTPs and providing medications for opioid treatment. Computalogic’s vision is providing a clinic management software that can adjust to the needs of the providers battling the opioid epidemic. As healthcare providers who worked in OTPs for decades, Computalogic’s team has created a truly unique solution that understands those providers’ workflow and operations.

“We are excited to partner with AZZLY to serve more OTPs throughout the USA”, said Keith Jones, Founder & CEO of Computalogic.

This seamless integration between MethodOne and AZZLY Rize empowers addiction treatment providers to streamline their clinical and business processes and efficiently treat more patients. AZZLY and Computalogic’s modern, cloud-based systems are a perfect fit to allow OTPs to provide greater, more efficient services to their clients and to speed reimbursement of services.

“We are excited to work with dedicated addiction treatment providers and fellow entrepreneurs that are committed to improving treatment outcomes” commented Coletta Dorado, CEO and Founder of AZZLY, Inc. “We are being approached by more MOUD organizations that understand the benefit of an all-in-one solution that fits their unique needs.”

About AZZLY®

AZZLY® Inc., founded in 2009 by Coletta Dorado, is a leading mental health and addiction treatment software technology company, providing a unique, all in one EHR, Patient Management (PM) and Revenue Cycle Management (RCM) solutions in an affordable all-in-one platform solution AZZLY Rize™. Having lost loved ones to addiction, she and her team committed themselves to listen, and invest the resources to build a better, medically based, clinical and business software. A 2020 market study named AZZLY a key player in the Global Patient Care Management Software industry. Email hello@azzly.com or visit azzly.com for more information.

About MethodOne® by Computalogic®

MethodOne® is a leader in their field with a unique perspective on dispensing software for medication assisted treatment centers. Keith Jones founded Computalogic® in 2004. As the owner and administrator of multiple OTPs, Keith grew frustrated with his options for clinic management software which seemed to lack the basic understanding of MAT operations and workflow, and he set out to create an alternative. It was crucial it be affordable for clinics to use, user-friendly, customizable, and demonstrate a practical understanding of MAT procedures. Contact Computalogic at info@computalogic.com or (724) 371-1199 to discuss MethodOne.

Share article on social media or email:

“As the stimulant epidemic continues to rage nationwide, the need for education, awareness, and progress is critical,” said John L. Eadie, Public Health and PDMP Project Coordinator, National Emerging Threats Initiative.

MALVERN, Pa. (PRWEB)
September 28, 2021

As the U.S continues to experience a significant uptick in overdoses related to the misuse of prescription and illicit stimulants, HMP Global, the leader in healthcare events and education, today announced that the fourth annual Cocaine, Meth & Stimulant Summit (STIM) will take place online October 14-16, 2021 via the company’s proprietary VRTX event platform. The event will feature a roster of experts who possess a deep understanding of approaches and strategies to directly address this growing national epidemic.

According to provisional data released by the Centers for Disease Control and Prevention, 81,000 drug overdose deaths occurred during the 12-month period from June 2019 to May 2020, with a sharp increase in those involving stimulants. Currently in the United States, there are 2.2 million users of cocaine and 6 million Americans misusing prescription stimulants. There are currently no FDA-approved medications available to treat stimulant use disorder.

The annual Summit, designed to cater to an array of professionals – including physicians, nurses, psychologists, and law enforcement personnel who are directly involved with addressing this epidemic – features both a clinical track and a law enforcement and public safety track.

Slated to present at the Summit are the following experts:

• 
  Sam Quinones, former LA Times journalist and author of Dreamland as well as the forthcoming The Least of Us: True Tales of America and Hope in the Age of Fentanyl and Meth, will deliver the Keynote Address entitled, “How an Opioid Epidemic Became a Meth Epidemic, Too” on Friday, October 15 at 10:00 am EDT.
• Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA), will present “Researching Treatments for Stimulant Use Disorder—Insight from the National Institute on Drug Abuse” on Thursday, October 14 at 4:30 pm EDT.
• John L. Eadie, MPA, of the Public Health and Prescription Drug Monitoring Program Project; National Emerging Threats Initiative will present “The National Stimulant Use Landscape: Reviewing Data and Trends” on Thursday, October 14 at 10:00 am EDT.

“As the stimulant epidemic continues to rage nationwide, the need for education, awareness, and progress is critical,” said John L. Eadie, Public Health and PDMP Project Coordinator, National Emerging Threats Initiative in Rensselaer, New York. “The Stimulant Summit demonstrates a collaborative effort of clinical, law enforcement, and public health professionals who will provide attendees with the most up-to-date insight regarding how to best address this widespread issue.”

Attendees can earn 15 credits live and 25 credits on-demand. The Summit is supported by organizations including the National Safety Council and the Public Health and Prescription Drug Monitoring Program Project; National Emerging Threats Initiative, A National HIDTA Initiative.

For more information, visit stimulantsummit.com. For media inquiries, contact pr@hmpglobal.com.

ABOUT HMP GLOBAL

HMP Global is the force behind Healthcare Made Practical—and is an omnichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events – in person and online via its proprietary VRTX virtual platform – and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Share article on social media or email:

Crushing The 2021 Recovery Month With Help From The Experts In Addiction Treatments

everyone plays a major role in increasing awareness and encouraging the importance of understanding substance abuse and mental disorders

TEMPE, Ariz. (PRWEB)
September 23, 2021

Understanding Recovery Month

Millions of Americans have successfully transformed their lives through drug recovery. These successful cases go unnoticed by the majority of the population most of the time, however. Recovery Month provides the perfect vehicle for everyone to celebrate these achievements. Thousands of prevention, treatment, and recovery facilities around the nation promote and celebrate Recovery Month each September by sharing the accomplishments made by those in recovery with the community. This way, everyone plays a major role in increasing awareness and encouraging the importance of understanding substance abuse and mental disorders.

Overdose Statistics In The United States

Overdose deaths increased significantly in almost every state during 2020. According to the Centers for Disease Control and Prevention 28 states had more than a 30 percent increase in overdose deaths in 2020 compared to 2019, including 10 states that increased by more than 40 percent. Pandemic lockdowns made getting treatment difficult and unfortunately contributed to the number of Americans who died of drug overdoses last year, as many recovering addicts have relapsed during these events. Data shows that opioids were involved in 74.7 percent of overdose deaths, rising to 69,710 in 2020 from 50,963 in 2019. Preliminary data shows that 418 overdose deaths occurred during the first three months of 2021 compared to 378 overdose deaths in the first three months of 2020. 46 percent of these deaths are linked to fentanyl.

Alcohol & Drug Abuse Trends In Arizona

One of the most devastating drug and alcohol abuse trends in Arizona is the rapid rise in deaths caused by opioid overdose. Over 3 Arizonans a day have perished from opioid overdose in the last two years. From all types of opioids that we find to have contributed to this alarming rise in deaths, Fentanyl was the most commonly used painkillers in 2019-2020. Fentanyl is a synthetic opioid that is 50 to 100 times more potent than morphine, and has greatly contributed to the majority of deaths caused by overdose. Arizona is also seeing a rise in the use of methamphetamines, and tranquilizer drugs such as Xanax. COVID-19-related stress has also played a significant role in the number of substance abuse deaths that have occurred in Arizona this year.

Making Outpatient Recovery A Reality For Better Longer Lasting Results

Since 2015, Corebella Health & Wellness has earned a reputation for being one of the leading health care providers in the Tempe, Glendale, and Scottsdale areas. Our highly trained, board-certified providers offer a wide range of services including outpatient addiction treatment, individual counseling and group counseling, primary care, and interventional pain management. Having specialized in the recovery field for over 6 years, Corebella Health & Wellness has witnessed the positive reality of recovery. Individuals who embrace recovery achieve improved mental and physical health and form stronger relationships with their neighbors, family members, and peers. We know recovery is possible, and we strive to let our patients know they can achieve it.

Furthermore, having recognized our patient’s needs, Corebella is excited to announce the addition of psychiatric services to our treatment options. Corebella is a fully integrated holistic addiction treatment program capable of supporting all our patient’s treatment needs.

Seek Advice & Coping Tips From Experts In Addiction Treatment

Corebella is celebrating Recovery Month by sharing a variety of educational content in order to assist individuals and families who are working to conquer addiction and live their best lives. From diet tips to assist with physical and mental withdrawal to everyday wellness strategies to support your journey to wellness.

Recovery Is Possible – Everyone Deserves A Full Life.

Recovery from mental disorders and/or substance abuse disorders is a process of change through which individuals: Improve their health and wellness, live a self-directed life, and strive to achieve their full potential. Our goal is to help more people recognize recovery is possible. Mental health and substance use disorders affect people of all ethnicities, ages, genders, geographic regions, and socioeconomic levels. They need to know that help is available. Whether facing alcoholism, opioids, heroin, cocaine, or painkiller addiction, we know that these individuals can get better, both physically and emotionally, with the support of a welcoming community.

Corebella Health & Wellness

Tempe Location

2600 E Southern Ave Suite E-1

Tempe, Arizona 85282

Office: (480) 409-0322

Glendale Location

5700 W Olive Ave, Suite 107

Glendale, AZ 85302

Office: (602) 4929595

Scottsdale Location

6565 E Greenway Parkway Suite 102,

Scottsdale, AZ 85254

Office: (602) 649-0677

Email: admin@corebellawellness.com

Share article on social media or email:

MEADVILLE, Pa. (PRWEB)
September 06, 2021

“Wings of Love and Support”: an encouraging and inspiring arrangement of writings. “Wings of Love and Support” is the creation of published author Tombo, a native of Wisconsin who retired to Arizona after working in education for thirty years.

Tombo shares, “Smokers who quit cannot undo all the damage done to their lungs. But they can reduce the problems in the future. Knowing there will be future benefits from not smoking should inspire them to quit the habit. The future can be changed, but the past has to be accepted. When the habit is kicked, so should guilt and regret for past actions be kicked from our memory. Concentration should be on the future and not what has happened in the past.

“Our Higher Power and the group allow do-overs just like kids do in a game. The people in the meeting will love and support the new us with open arms. Their strength and guidance is available many hours a day. Neither night nor day, summer nor winter, nor past practices will be obstacles from receiving help from our fellow recovering addicts. They have an inexhaustible supply of love ready to be given as needed. All we need to do is ask.

“Once we ask for help, change can occur. That change will affect the outcome of our life. Our past will no longer be relevant to our future. Only our present effort will be counted.

“Start today by forgetting the past. Focus on your recovery and change your future. Seek help and active support to make that vital change. Pray, read the Combo Book and other uplifting materials, seek assistance from friends, and begin the task of changing your old habits. Replace those old negative habits with fresh new vibrant and positive habits. It’s never too late!”

Published by Christian Faith Publishing, Tombo’s new book is presented in hopes of reaching those who need help focusing on the future and forgiving the past.

Tombo’s personal experiences with addiction and the gentle guidance received through twelve-step programs has culminated in this helpful and hopeful tome.

View a synopsis of “Wings of Love and Support” on YouTube.

Consumers can purchase “Wings of Love and Support” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Wings of Love and Support,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

The results of this new fentanyl detox program are ground breaking, as it addresses many of the concerns patients have in starting their journey to lifelong recovery.

DENVER (PRWEB)
August 12, 2021

Gallus Medical Detox Centers (Gallus), a national leading inpatient drug and alcohol medical detox services provider, announces today the launch of a new inpatient medical detoxification protocol for fentanyl that has been clinically shown to reduce withdrawal symptoms, shorten treatment time and help patients successfully detox in order to transition to treatment and long-term recovery.

Patients using the new accelerated micro induction (AMI) protocol for opioid use disorder (OUD) with fentanyl reported a significantly lower Clinical Opiate Withdrawal Scale score (COWS), an 11-item scale designed to help clinicians determine the severity of opiate withdrawal (1). Gallus found that the new treatment process lowered COWS scores an average of 4.4 points, or 42% a day, over the three days prior to full induction. Patient treatment time was also reduced by 15%.

“The results of this new fentanyl detox program are ground breaking, as it addresses many of the concerns patients have in starting their journey to lifelong recovery,” says Shannon Weir, RN, Director of Clinical Education and Quality Assurance at Gallus. “Continuous improvement of our evidence-based medical detox protocols, combined with an ongoing commitment to prepare patients for aftercare treatment, provides a solid foundation for recovery.”

In addition to the Gallus Method achieving dramatic improvement in managing withdrawal symptoms, new patient research is showing a clinically and statistically significant decrease in depression, an average drop of 5.88 points, during inpatient medical detox treatment as measured using the PHQ-9.

Currently, Gallus’ rate of patient transition to aftercare is 85%, as compared to estimates of 15% when detox services are provided in a hospital setting. This new AMI protocol is expected to increase the number of patients who enter OUD treatment as well as aftercare.

“Gallus’ decade of medical experience and front-line exposure to evolving SUD trends affords us the unique ability to focus on continually improving treatment outcomes,” said Doug Weiss, President & CEO of Gallus. “By using our expertise and knowledge of how substances impact our patients, we can fulfill our commitment to excellence in providing patients with safe, comfortable and effective medical detox treatment as the first step in their recovery journey.”

Gallus Medical Detox Centers’ evidence-based medical detox services for substance use disorders include alcohol, opioid, benzodiazepines, stimulants, polysubstance and others. It also has the expertise to treat patients with acute substance use disorders and co-occurring mental health or chronic physical conditions.

The Gallus AMI treatment protocol is being offered at its locations in Scottsdale, Arizona and Littleton, Colorado. For those who are seeking professional help to treat a substance use disorder, please visit gallusdetox.com or call 888-306-3122 for Admissions. Gallus also offers community updates and alerts on substance use trends through The Pulse, a newsletter available on the website.

(1) Clinical Opiate Withdrawal Scale (drugabuse.gov)

About Gallus Medical Detox Centers

A national Center of Excellence, Gallus Medical Detox Centers provide the highest quality inpatient medical detox services using evidence-based IV medication protocols that avoid cross-addiction, delivered by highly trained medical staff, in a safe, comfortable and private patient environment that optimizes treatment outcomes.

With locations in Arizona and Colorado, Gallus’ vision is to be the best, first step in overcoming substance use disorders for patients needing medical detox and to lead the field in the science, education, training and customer experience. Through the Gallus Method, patients receive unique, personalized and 24-hour care delivered in a professional, safe and peaceful environment to achieve an optimal physiological withdrawal experience that will move them into behavioral health therapy and ultimately find long-term recovery.

Share article on social media or email:

John Brooks Recovery Center searches for naming rights sponsors for its new residential treatment facility in Mays Landing.

“This is an exciting time in the life of John Brooks Recovery Center as we unveil various opportunities for naming rights to the community,” said Michael Santillo, CEO of JBRC.

MAYS LANDING, N.J. (PRWEB)
August 03, 2021

Help John Brooks Recovery Center (JBRC) give the gift of hope. Following its 50th year serving the community, JBRC recently opened its new residential treatment facility in Mays Landing. In conjunction with the opening, JBRC has announced it is now searching for naming rights sponsors for the facility. Naming rights start at $1,000 for bedrooms at the treatment centers and goes up to $1M for the entire building. Giving plans are also available, including five-year payment plans. Those interested in learning more about becoming a part of the John Brooks legacy should call 609-345-2020, ext. 6138.

“This is an exciting time in the life of John Brooks Recovery Center as we unveil various opportunities for naming rights to the community,” said Michael Santillo, CEO of JBRC. “Together, we can help individuals overcome substance use disorders and provide hope, recovery and healing to all for a better tomorrow.”

Since 1969, JBRC’s mission has been to provide quality, scientifically based, individualized substance use treatment services to New Jersey residents for the prevention, reduction and elimination of the harm caused by substance use disorders. JBRC’s new $18M Mays Landing residential treatment facility offers a recovery-oriented model that integrates physical health, behavioral health and recovery support services. This new facility offers 46 short-term beds, 46 long-term beds and 23 detox beds, and will expand its current continuum of care.

“Our programs are clinically driven with a length of stay from 3-6 months for long-term residential and consist of individual, group and family counseling, psychoeducation classes, medication assisted treatment, recreation, psychiatric services, medical services and education services,” Santillo said.

JBRC provides a host of treatment options that attest to its success, as well as two recovery community centers, a recovery housing program and physical health. This month, the nonprofit opened the doors to its new residential treatment facility in Mays Landing that expands its current continuum of care and allows the organization to serve even more people. In conjunction with the opening, JBRC also unveiled a refreshed brand identity and was also named #1 Gold Drug and Alcohol Recovery Program by Best of the Press 2020.

Throughout all its endeavors and accolades, JBRC has remained focused on one thing – to help individuals who are struggling with substance use disorder to achieve recovery. “Our goal is to provide the highest quality, evidence-based treatment services to help individuals overcome substance use disorders regardless of financial circumstance or socio-economic background,” said Santillo.

JBRC’s new residential treatment facility, located at 1455 Pinewood Boulevard in Mays Landing, is now accepting new patients and referrals. To learn more, call 609-345-2020, ext. 6138.

About John Brooks Recovery Center

Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication Assisted Recovery and Inmate Re-entry. To learn more, visit jbrcnj.org or visit them on Facebook @JohnBrooksRecoveryCenter.

CEO: Michael Santillo, LCADC

Board of Directors (Officers): Harriet Weintrob, President; Edwin G. Blake, Vice President; Linda D. Peyton, Secretary, and Stuart Stromfeld, Treasurer.

Board Members (Officers): Rev. Collins Days, Larry Horowitz, Jack Fox, Carolyn Greenidge, Gary D. Callender, Pamela Sinderbrand and Sandra E. Garrett Dorsey.

About All Roads Recovery Community Center

All Roads Recovery Community Center, the community-based recovery arm of JBRC, helps anyone struggling with addiction navigate their next steps on the journey to recovery. All Roads currently offers a wide variety of Recovery Groups, as well as one-on-one coaching with Certified Peer Recovery Specialists (CPRS). To learn more, visit allroadsrecovery.org, call 609-457-1080 or visit them on Facebook @AllRoadsRCC.

https://jbrcnj.org/news/

Share article on social media or email: